Nrx Pharma Enrolls First Patient In Phase Ii Study Of Bipolar Depression With Sub-Acute Suicidality

Nrx Pharma Enrolls First Patient In Phase Ii Study Of Bipolar Depression With Sub-Acute Suicidality

By, Admin 15 June 2022

Nrx Pharmaceuticals, Inc., A Clinical-Stage, Biopharmaceutical Company, Announced That The First Patient Has Been Enrolled In One Of The Two Psychiatry Studies That It Plans To Initiate This Year: This First Trial Is Studying Patients With Bipolar Depression And Sub-Acute Suicidality (Not Requiring Hospitalization). In The Second Half Of This Year, Nrx Pharmaceuticals Expects To Initiate A Phase Iib/Iii Registrational Trial In Patients With Bipolar Depression And Acute Suicidal Ideation And Behaviour (Asib), Which Requires Hospitalization Of The Patient. The Us Food And Drug Administration (Fda) Previously Awarded Breakthrough Therapy Designation For Nrx-101 For This Last Indication, Based On Positive Phase Ii Data That The Company Submitted.Nrx-101 Is An Oral, Patented, Fixed-Dose Combination Product Of D-Cycloserine And Lurasidone. D-Cycloserine Exhibits Partial Nmda Receptor Antagonist Activity At Specific Dosages. Both Components Are Approved Drugs That Are Not Scheduled, As Available Data Has Not Shown Potential For Abuse. This Is Important

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!